Cernunnos deficiency: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 33: | Line 33: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Autosomal_recessive_-_en.svg|Diagram of autosomal recessive inheritance | |||
File:Protein_NHEJ1_PDB_2QM4.png|Structure of the NHEJ1 protein | |||
File:IgM_scheme.svg|Schematic of IgM antibody | |||
</gallery> | |||
Revision as of 01:29, 18 February 2025
Cernunnos deficiency is a rare genetic disorder characterized by a deficiency in the Cernunnos protein, which plays a crucial role in the repair of DNA double-strand breaks. This condition is also known as XLF deficiency or NHEJ1 deficiency, named after the gene that encodes the Cernunnos protein.
Symptoms
The symptoms of Cernunnos deficiency can vary widely among affected individuals. Common symptoms include microcephaly (small head size), growth retardation, immune deficiency, and increased susceptibility to cancer. Some individuals may also have radiosensitivity, which means they are more sensitive to radiation than normal.
Causes
Cernunnos deficiency is caused by mutations in the NHEJ1 gene, which provides instructions for making the Cernunnos protein. This protein is involved in the process of non-homologous end joining (NHEJ), a method that cells use to repair DNA double-strand breaks. Mutations in the NHEJ1 gene disrupt the function of the Cernunnos protein, leading to an increased risk of DNA damage and the associated symptoms of Cernunnos deficiency.
Diagnosis
Diagnosis of Cernunnos deficiency is based on the presence of characteristic symptoms, a detailed patient history, and specialized laboratory tests. Genetic testing can confirm a diagnosis by identifying a mutation in the NHEJ1 gene.
Treatment
There is currently no cure for Cernunnos deficiency. Treatment is symptomatic and supportive, and may include regular monitoring for cancer, immune system support, and management of other symptoms as needed.
See also
References
<references />


